NATURE'S FIRST RESPONDER
NantKwest, Inc.
Application Filed: 2018-03-07
Trademark Application Details
SU - NON-FINAL ACTION - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87824141 |
| Registration Number | 6059246 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Alicia M. Passerin |
| Attorney Docket Number | NKW-21 |
| Law Office Assigned | M40 |
| Employee Name | FRYE, KIMBERLY |
Timeline
| 2018-02-26 | Date of First Use |
| 2018-03-07 | Application Filed |
| 2018-07-24 | Published for Opposition |
| 2019-10-16 | Location: TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED |
| 2019-10-16 | Status: Live/Pending |
| 2019-10-16 | Transaction Date |
| 2020-05-19 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  NantKwest, Inc. |
| Address | 9920 Jefferson Boulevard Culver City DE 90232 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes |
| GS0011 | Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-03-10 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-03-14 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-06-19 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-06-20 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-07-04 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-07-24 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-07-24 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-09-18 | 8 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2019-02-15 | 9 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-03-09 | 10 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2019-02-15 | 11 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-03-09 | 12 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2019-03-26 | 13 DOCK D:Assigned to Examiner |
| SU - NON-FINAL ACTION - WRITTEN | 2019-03-27 | 14 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2019-03-27 | 15 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-03-27 | 16 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-09-17 | 17 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2019-09-24 | 18 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-09-24 | 19 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-09-24 | 20 TEME I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2019-10-16 | 21 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2019-10-16 | 22 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-10-16 | 23 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-04-09 | 24 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-09 | 25 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-09 | 26 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-04-11 | 27 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-04-14 | 28 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-05-19 | 29 R.PR A:Allowance for Publication |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2021-06-09 | 30 ASGN I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 